Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for ...

The company’s mRNA flu shot, if approved, could be available for the 2026-27 flu season.

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused ...

By Deanna Neff HealthDay ReporterTHURSDAY, Feb. 19, 2026 (HealthDay News) — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval.

Add Yahoo as a preferred source to see more of our stories on Google. People who get a flu shot are less likely to become severely ill, be hospitalized or die. - Kylie Cooper/Reuters/File Flu is ...

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...

After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...